paper-with-me

홈 › Papers

An Agentic System for Rare Disease Diagnosis with Traceable Reasoning

2025-06-25 · Weike Zhao, Chaoyi Wu, Yanjie Fan, Xiaoman Zhang, Pengcheng Qiu, Yuze Sun, Xiao Zhou, Yanfeng Wang, Ya zhang, Yongguo Yu, Kun Sun, Weidi Xie

Rare diseases collectively affect over 300 million individuals worldwide, yet timely and accurate diagnosis remains a pervasive challenge. This is largely due to their clinical heterogeneity, low individual prevalence, and the limited familiarity most clinicians have with rare conditions. Here, we introduce DeepRare, the first rare disease diagnosis agentic system powered by a large language model (LLM), capable of processing heterogeneous clinical inputs. The system generates ranked diagnostic hypotheses for rare diseases, each accompanied by a transparent chain of reasoning that links intermediate analytic steps to verifiable medical evidence. DeepRare comprises three key components: a central host with a long-term memory module; specialized agent servers responsible for domain-specific analytical tasks integrating over 40 specialized tools and web-scale, up-to-date medical knowledge sources, ensuring access to the most current clinical information. This modular and scalable design enables complex diagnostic reasoning while maintaining traceability and adaptability. We evaluate DeepRare on eight datasets. The system demonstrates exceptional diagnostic performance among 2,919 diseases, achieving 100% accuracy for 1013 diseases. In HPO-based evaluations, DeepRare significantly outperforms other 15 methods, like traditional bioinformatics diagnostic tools, LLMs, and other agentic systems, achieving an average Recall@1 score of 57.18% and surpassing the second-best method (Reasoning LLM) by a substantial margin of 23.79 percentage points. For multi-modal input scenarios, DeepRare achieves 70.60% at Recall@1 compared to Exomiser's 53.20% in 109 cases. Manual verification of reasoning chains by clinical experts achieves 95.40% agreements. Furthermore, the DeepRare system has been implemented as a user-friendly web application http://raredx.cn/doctor.

📄 PDF Abstract BibTeX arXiv:2506.20430

Code (0)

등록된 구현이 없습니다.

Tasks

DiagnosticLarge Language Model

Similar Papers 제목 키워드 기반

End-to-End Agentic RAG System Training for Traceable Diagnostic Reasoning

2025-08-21 · Qiaoyu Zheng, Yuze Sun, Chaoyi Wu, Weike Zhao 외 arxiv

The integration of Large Language Models (LLMs) into healthcare is constrained by knowledge limitations, hallucinations, and a disconnect from Evidence-Based Medicine (EBM). While Retrieval-Augmented Generation (RAG) off…

Reinforcement Learning

Evo-RAD: Navigating Rare Retinal Disease Diagnosis via Self-Evolving Agentic Retrieval

2026-06-22 · Wangding Xia, Ye Du, Jiashi Lin, Meng Wang 외 arxiv

Large-scale pretrained foundation models have revolutionized general medical screening, but often falter on rare diseases because such conditions are underrepresented in real-world clinical datasets. While retrieval-augm…

parameter-efficient fine-tuning

DermAgent: A Self-Reflective Agentic System for Dermatological Image Analysis with Multi-Tool Reasoning and Traceable Decision-Making

2026-05-14 · Yize Liu, Siyuan Yan, Ming Hu, Lie Ju 외 arxiv

Dermatological diagnosis requires integrating fine-grained visual perception with expert clinical knowledge. Although Multimodal Large Language Models (MLLMs) facilitate interactive medical image analysis, their applicat…

Clinical Knowledge

Teaching agentic AI to learn expert reasoning for rare disease diagnosis

2026-06-15 · Minh-Ha Nguyen, Erica Gray, Bryce A. Schuler, Chih-Ting Yang 외 arxiv

Rare disease diagnosis depends on expert reasoning that is scarce and difficult to transfer; off-the-shelf large language models (LLMs) rank the correct disease first in only 35.4% of benchmark cases. Here we show that t…

PPGL-Swarm: Integrated Multimodal Risk Stratification and Hereditary Syndrome Detection in Pheochromocytoma and Paraganglioma

2026-03-23 · Zelin Liu, Xiangfu Yu, Jie Huang, Ge Wang 외 arxiv

Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors, of which 15-25% develop metastatic disease with 5-year survival rates reported as low as 34%. PPGL may indicate hereditary syndromes requiring …

Reinforcement Learning